ISSN:

Journal Home

Journal Guideline

Assay and Drug Development Technologies Q3 Unclaimed

Mary Ann Liebert Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Assay and Drug Development Technologies is a journal indexed in SJR in Drug Discovery and Molecular Medicine with an H index of 67. It has an SJR impact factor of 0,308 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,308.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q3) Molecular Medicine (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,308

SJR Impact factor

67

H Index

33

Total Docs (Last Year)

114

Total Docs (3 years)

2120

Total Refs

186

Total Cites (3 years)

104

Citable Docs (3 years)

1.55

Cites/Doc (2 years)

64.24

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Chemotherapy Q3
Future Medicinal Chemistry Q3
Biomarkers in Medicine Q3
Journal of Basic and Clinical Physiology and Pharmacology Q3
Journal of Antibiotics Q3

Compare this journals